203 related articles for article (PubMed ID: 19267849)
1. Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.
Wingard CJ; Moukdar F; Prasad RY; Cathey BL; Wilkinson L
J Sex Med; 2009 Mar; 6 Suppl 3(Suppl 3):269-78. PubMed ID: 19267849
[TBL] [Abstract][Full Text] [Related]
2. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat.
Wingard C; Fulton D; Husain S
J Sex Med; 2007 Mar; 4(2):348-62; discussion 362-3. PubMed ID: 17367430
[TBL] [Abstract][Full Text] [Related]
3. RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction.
Bivalacqua TJ; Champion HC; Usta MF; Cellek S; Chitaley K; Webb RC; Lewis RL; Mills TM; Hellstrom WJ; Kadowitz PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9121-6. PubMed ID: 15184671
[TBL] [Abstract][Full Text] [Related]
4. Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction.
Wingard CJ; Johnson JA; Holmes A; Prikosh A
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1572-9. PubMed ID: 12573976
[TBL] [Abstract][Full Text] [Related]
5. Change of erectile function and responsiveness to phosphodiesterase type 5 inhibitors at different stages of streptozotocin-induced diabetes in rats.
Cho SY; Park K; Paick JS; Kim SW
J Sex Med; 2011 May; 8(5):1352-61. PubMed ID: 21054802
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
[TBL] [Abstract][Full Text] [Related]
7. Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes.
Vignozzi L; Morelli A; Filippi S; Ambrosini S; Mancina R; Luconi M; Mungai S; Vannelli GB; Zhang XH; Forti G; Maggi M
J Sex Med; 2007 May; 4(3):620-632. PubMed ID: 17498101
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of an oral Rho kinase inhibitor prevents the development of vasculogenic erectile dysfunction in a rat model.
Park K; Kim SW; Rhu KS; Paick JS
J Sex Med; 2006 Nov; 3(6):996-1003. PubMed ID: 17100932
[TBL] [Abstract][Full Text] [Related]
9. Apocynin improves erectile function in diabetic rats through regulation of NADPH oxidase expression.
Li M; Zhuan L; Wang T; Rao K; Yang J; Yang J; Quan W; Liu J; Ye Z
J Sex Med; 2012 Dec; 9(12):3041-50. PubMed ID: 23088159
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
Rajasekaran M; White S; Baquir A; Wilkes N
J Androl; 2005; 26(2):182-8. PubMed ID: 15713824
[TBL] [Abstract][Full Text] [Related]
11. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction.
Jin L; Liu T; Lagoda GA; Champion HC; Bivalacqua TJ; Burnett AL
FASEB J; 2006 Mar; 20(3):536-8. PubMed ID: 16396994
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
[TBL] [Abstract][Full Text] [Related]
13. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
14. A protein tyrosine kinase inhibitor, imatinib mesylate (Gleevec), improves erectile and vascular function secondary to a reduction of hyperglycemia in diabetic rats.
Gur S; Kadowitz PJ; Hellstrom WJ
J Sex Med; 2010 Oct; 7(10):3341-50. PubMed ID: 20584116
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Lund DD; Yorek MA
Obesity (Silver Spring); 2008 Jan; 16(1):82-9. PubMed ID: 18223617
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
Sezen SF; Lagoda G; Musicki B; Burnett AL
J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
[TBL] [Abstract][Full Text] [Related]
18. Long-term administration of rosuvastatin prevents contractile and electrical remodelling of diabetic rat heart.
Ozturk N; Yaras N; Ozmen A; Ozdemir S
J Bioenerg Biomembr; 2013 Aug; 45(4):343-52. PubMed ID: 23640692
[TBL] [Abstract][Full Text] [Related]
19. A Toll-Like Receptor 1/2 Agonist Augments Contractility in Rat Corpus Cavernosum.
Stallmann-Jorgensen I; Ogbi S; Szasz T; Webb RC
J Sex Med; 2015 Aug; 12(8):1722-31. PubMed ID: 26234560
[TBL] [Abstract][Full Text] [Related]
20. The selective Rho-kinase inhibitor azaindole-1 has long-lasting erectile activity in the rat.
Lasker GF; Pankey EA; Allain AV; Murthy SN; Stasch JP; Kadowitz PJ
Urology; 2013 Feb; 81(2):465.e7-14. PubMed ID: 23374844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
